Clinical Trials Directory

Trials / Completed

CompletedNCT01410006

Neurofibromatosis Type 1 Patient Registry

Status
Completed
Phase
Study type
Observational
Enrollment
2,391 (actual)
Sponsor
Washington University School of Medicine · Academic / Other
Sex
All
Age
Healthy volunteers
Accepted

Summary

The Neurofibromatosis Type 1 (NF1) Patient Registry Initiative (NPRI) is a web-based registry that asks participants to fill out a 30-minute online questionnaire to collect information about the spectrum of medical and social problems experienced by children and adults with NF1. The information gained from your participation may one day help doctors develop personalized treatments for individuals living with NF1. We are currently enrolling individuals with NF1 who either (1) HAVE previously been diagnosed with a brain tumor younger than 18 years or (2) HAVE NEVER had a brain tumor. Please note: there is no therapy associated with this study. Individuals may participate in the registry by going to https://nf1registry.wustl.edu/

Conditions

Timeline

Start date
2011-05-01
Primary completion
2017-07-01
Completion
2017-07-01
First posted
2011-08-04
Last updated
2017-07-25

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01410006. Inclusion in this directory is not an endorsement.